PP
ALXA

PDT Partners’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

PDT Partners’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,500
Closed -$24K – 1319
2014
Q3 		$24K Buy
+10,500
New +$40.1K ﹤0.01% 1259

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PDT Partners's ALXA Position: Q4 2014 in Review

PDT Partners sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2014, closing a stake of 10,500 shares — an estimated $24K sold.

PDT Partners first reported a position in ALXA in Q3 2014 and held it in 1 quarter. The position peaked at $24K in Q3 2014. 31 funds tracked by Wall St. Rank hold ALXA as of Q4 2014.

  • PDT Partners reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • PDT Partners sold 10,500 Alexza Pharmaceuticals Inc shares in Q4 2014, an estimated $24K.
  • PDT Partners first reported a position in Alexza Pharmaceuticals Inc in Q3 2014 and held it in 1 quarter.
  • PDT Partners's Alexza Pharmaceuticals Inc position peaked at $24K in Q3 2014.
  • 31 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2014.

Based on PDT Partners's 13F filing for Q4 2014, filed 17 Feb 2015.